Radiotherapy Market by Technology (EBRT: LINAC, Stereotactic, Particle; Internal Beam/Brachytherapy, Cobalt-60 Teletherapy), Procedure (IGRT, IMRT, 3D-CRT, LDR, PDR), Cancer (Prostate, Lung, Breast, CRC), End User (Hospital, IRC) - Global Forecast to 2031

icon1
USD 10.68 BN
MARKET SIZE, 2031
icon2
CAGR 6.0%
(2026-2031)
icon3
350
REPORT PAGES
icon4
304
MARKET TABLES

RADIOTHERAPY MARKET SIZE, SHARE & GROWTH SNAPSHOT

radiotherapy-monitoring-devices-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global radiotherapy market is projected to grow from USD 7.98 billion in 2026 to USD 10.68 billion by 2031, at a CAGR of 6.0% during the forecast period. The market was valued at USD 7.58 billion in 2025. The growth of the radiotherapy market is driven by several factors, including the rising global incidence of cancer, increased spending on healthcare facilities, and growing demand for precision oncology treatments. The rapid adoption of innovative applications such as proton beam therapy, adaptive radiotherapy, stereotactic radiosurgery, and artificial intelligence-based treatment planning is improving the accuracy of tumor treatment while minimizing damage to surrounding tissues.

KEY TAKEAWAYS

  • BY REGION
    By region, the Asia Pacific is projected to witness the highest CAGR of 7.1% during the forecast period.
  • BY OFFERING
    By offering, the systems segment accounted for the largest market share of 55.5% in 2025.
  • BY TECHNOLOGY
    By technology, the external beam radiotherapy segment is expected to register the highest CAGR of 5.7% during the forecast period.
  • BY APPLICATION
    By application, the EBRT applications segment dominated the market with a share of 96.0% in 2025.
  • BY PROCEDURE
    By procedure, the external beam radiotherapy procedures segment accounted for the largest market share of 96.0% in 2025.
  • BY END USER
    By end user, the hospitals segment is projected to grow at the fastest rate of 5.7% from 2026 to 2031.
  • COMPETITIVE LANDSCAPE - KEY PLAYERS
    Siemens Healthineers AG (Varian Medical Systems, Inc.) (Germany), Elekta (Sweden), Accuray Incorporated (US), IBA Worldwide (Belgium), and ViewRay, Inc. (US) are identified as star players in the radiotherapy market, given their strong global market presence, extensive portfolios, advanced R&D capabilities, and well-established distribution networks across developed and emerging regions.
  • COMPETITIVE LANDSCAPE - OTHER PLAYERS
    These companies offer unique products that have started occupying a niche for themselves within the industry. Their business and product superiority is yet to be matched when compared to some other leading start-up firms. Some of the most successful firms in this segment include Brainlab AG (Germany) and BEBIG Medical (Germany).

The growth of the radiotherapy market is driven by several factors, including the rising global incidence of cancer, increased healthcare spending, and a growing demand for precision oncology treatments. The rapid adoption of advanced applications such as proton beam therapy, adaptive radiotherapy, stereotactic radiosurgery, and artificial intelligence-based treatment planning is improving the accuracy of tumor treatment while minimizing damage to surrounding tissues.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

Several technological developments and trends are likely to significantly impact the radiotherapy market. Key advancements include sophisticated technologies such as Linear Accelerators (LINACs), proton therapy systems, MRI-guided radiotherapy systems, and stereotactic radiotherapy systems. Additionally, innovations such as artificial intelligence-based treatment-planning solutions, workflow optimization tools, and real-time tumor-tracking systems are expected to shape the market's future. The primary goal of these technological advancements is to enhance the efficacy of radiotherapy procedures. Recently, hypofractionated radiotherapy and image-guided treatment procedures have gained increasing popularity.

radiotherapy-monitoring-devices-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Advancements in radiotherapy treatments
  • Increasing use of advanced applications, including adaptive radiotherapy, stereotactic body radiation therapy (SBRT), and MRI-guided radiotherapy
RESTRAINTS
Impact
Level
  • Limited access to advanced radiotherapy facilities in low- and middle-income countries
  • Shortage of skilled radiation oncologists, medical physicists, and trained technicians
OPPORTUNITIES
Impact
Level
  • Emerging markets offering significant growth potential for radiotherapy technologies
  • AI-based treatment planning, automated contouring, and adaptive radiotherapy
CHALLENGES
Impact
Level
  • Regulatory complexity and lengthy approval timelines for advanced radiotherapy technologies
  • Managing treatment accuracy for moving tumors through real-time imaging and motion tracking

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Advancements in radiotherapy treatments

Technological advancements in radiotherapy have become a key factor driving the growth of the radiotherapy market. The increasing adoption of advanced treatment technologies, such as intensity-modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), MRI-guided linear accelerators (MRI-guided LINACs), adaptive radiotherapy, and AI-based treatment planning software, is significantly improving the precision of radiation doses, the accuracy of tumor targeting, and overall treatment efficiency while minimizing exposure to surrounding healthy tissues. Furthermore, the shift from conventional 2D radiotherapy to real-time image-guided and 3D conformal radiotherapy systems is enhancing clinical outcomes and broadening the applications of radiotherapy across hospitals and cancer care centers. Recent innovations, including AI-powered adaptive CT-LINAC systems, robotic radiosurgery platforms, and real-time motion tracking technologies, are further accelerating the global adoption of advanced radiotherapy solutions.

Restraint: Limited access to advanced radiotherapy facilities in low- and middle-income countries

Limited access to advanced radiotherapy facilities in low- and middle-income countries poses a significant barrier to the radiotherapy market. This issue stems from inadequate healthcare infrastructure, a shortage of skilled oncology professionals, and the high costs associated with advanced radiotherapy systems. Many healthcare facilities in emerging regions struggle to adopt technologies such as proton therapy, MRI-guided radiotherapy, and adaptive radiotherapy due to limited funding and insufficient reimbursement support. Additionally, the uneven distribution of cancer care centers and the delayed installation of advanced treatment systems continue to hinder patient access to precision oncology services. However, emerging trends like compact linear accelerator systems, AI-assisted treatment planning, cloud-based oncology workflows, and mobile radiotherapy solutions are expected to gradually enhance accessibility and operational efficiency in underserved regions.

Opportunity: Emerging markets offering significant growth potential for radiotherapy technologies

Emerging economies offer significant growth opportunities for the radiotherapy market due to the rising prevalence of cancer, improved healthcare infrastructure, and increased investments in oncology care in countries such as China, India, Brazil, and Mexico. Governments in these regions are boosting healthcare spending and enhancing access to advanced cancer treatment technologies. It is projected that government health expenditures will grow by 14% in low-income countries (LICs) and 17% in lower-middle-income countries (LMICs) between 2024 and 2030, which will support the expansion of radiotherapy infrastructure and oncology services. Additionally, the rise of medical tourism, lower treatment costs compared to developed countries, and the increasing adoption of advanced technologies such as AI-enabled radiotherapy, CyberKnife radiosurgery, and proton therapy are creating further significant growth opportunities for the radiotherapy market in emerging economies.

Challenge: Regulatory complexity and lengthy approval timelines for advanced radiotherapy technologies

Regulatory complexity and lengthy approval timelines for advanced radiotherapy technologies pose significant challenges for the radiotherapy market. Advanced systems, such as proton therapy, MRI-guided radiotherapy, adaptive radiotherapy platforms, and AI-based treatment planning software, require extensive clinical validation, safety assessments, and adherence to stringent regulatory standards before they can be commercialized. Variations in regulatory frameworks across different regions further prolong approval timelines and delay the launch of products for market players. Additionally, evolving regulations concerning AI integration, radiation safety, and software interoperability create ongoing operational and compliance challenges for manufacturers developing next-generation radiotherapy solutions.

RADIOTHERAPY MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Provides Varian LINACs and AI-enabled adaptive radiotherapy solutions. Improves treatment precision and adaptive workflow efficiency.
Offers MRI-guided and adaptive radiotherapy systems. Enables real-time imaging and accurate tumor targeting.
Delivers CyberKnife and Radixact radiotherapy platforms. Supports robotic radiosurgery and motion-tracked treatment delivery.
Provides proton therapy and particle therapy solutions. Minimizes radiation exposure to surrounding healthy tissues.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The stakeholders in the radiotherapy market include manufacturers of radiotherapy systems, providers of software and treatment planning solutions, component suppliers, distributors, hospitals, independent radiotherapy centers, and regulatory authorities. Companies in this market are focused on developing advanced radiotherapy systems, such as linear accelerators (LINACs), MRI-guided radiotherapy systems, particle therapy systems, brachytherapy solutions, and AI-enabled treatment planning platforms to enhance treatment precision and improve clinical outcomes. Suppliers and service providers contribute to the market by delivering consumables, software integration, installation, maintenance, and workflow optimization services. Hospitals and independent radiotherapy centers are the primary end users due to the growing demand for advanced cancer treatment procedures. Regulatory bodies, such as the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA), ensure the safety, efficacy, and approval of innovative radiotherapy technologies. Key companies operating within the radiotherapy ecosystem include Siemens Healthineers AG (Germany), Elekta (Sweden), Accuray Incorporated (US), IBA Worldwide (Belgium), Brainlab AG (Germany), and BEBIG Medical (Germany).

radiotherapy-monitoring-devices-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

RADIOTHERAPY MARKET, BY OFFERING

By offering, the radiotherapy market is divided into systems and software & services. The systems segment is expected to experience significant growth in the coming years due to the increasing popularity of technology-enabled radiotherapy equipment in developing countries and the rising number of manufacturers producing these advanced systems. This segment includes systems, consumables, probes, and applicators used in external beam radiation therapy and brachytherapy. Furthermore, the growing incidence of cancer, the increasing demand for precision radiotherapy, and ongoing advancements in technology are also contributing to the market's expansion.

RADIOTHERAPY MARKET, BY TECHNOLOGY

Based on technology, radiotherapy is segmented into external beam radiotherapy and internal beam radiotherapy/brachytherapy. The external beam radiotherapy segment is anticipated to have the largest market share among other segments during the forecast period, owing to its capability of providing highly accurate and precise tumor targeting without exposing adjacent healthy tissue to any unnecessary radiation. Growth in the adoption of more advanced procedures and increased demand for precision medicine are driving the growth of this segment.

RADIOTHERAPY MARKET, BY APPLICATION

By application, the radiotherapy market is segmented into external beam radiotherapy (EBRT) applications and internal beam radiotherapy (IBRT)/brachytherapy applications. During the forecast period, the external beam radiotherapy (EBRT) applications segment is poised to command the most substantial market share in the radiotherapy market. This dominance is fueled by the increasing adoption and efficacy of EBRT for new cancer types.

RADIOTHERAPY MARKET, BY PROCEDURE

By procedure, the radiotherapy market is segmented into external beam radiotherapy procedures and internal beam radiotherapy/brachytherapy procedures. The external beam radiotherapy procedures segment is estimated to dominate the radiotherapy market during the forecast period, owing to the non-invasive nature of this procedure, high degree of accuracy, low radiation exposure to nearby healthy cells, and increasing adoption of advanced technology-based devices. The rising requirement for personal cancer treatment, high incidence of cancer, and technological innovations are propelling the growth of this segment.

RADIOTHERAPY MARKET, BY END USER

On the basis of end user, the radiotherapy market is classified into hospitals and standalone radiotherapy centers. The hospitals segment will hold the largest share of the worldwide radiotherapy market in the coming years, due to the large volume of patients, availability of advanced radiotherapy equipment, and rising demand for complete cancer treatment facilities in hospitals. The other factors that will support the growth of this segment include the increasing number of hospitals in developing nations, investments in the healthcare infrastructure sector, and availability of trained oncologists.

REGION

Asia Pacific to be fastest-growing region in global radiotherapy market during forecast period

The Asia Pacific region is expected to register the highest CAGR in the radiotherapy market during the forecast period. Asia Pacific comprises China, India, South Korea, Australia, Japan, and the Rest of Asia Pacific. Growth is driven by the increasing prevalence of cancer, an aging population, expanding oncology infrastructure, and growing adoption of advanced radiotherapy equipment such as linear accelerators, image-guided radiation therapy, and proton therapy. Other factors driving the market include increased government spending, increased medical tourism, and collaborations between market vendors.

radiotherapy-monitoring-devices-market Region

RADIOTHERAPY MARKET: COMPANY EVALUATION MATRIX

The radiotherapy market is characterized by several established and emerging players operating across the Stars, Emerging Leaders, Pervasive Players, and Participants categories. Companies categorized as Stars, including Siemens Healthineers, Elekta, Accuray, IBA Worldwide, and ViewRay Technologies, hold strong market positions due to their broad product portfolios, advanced radiotherapy technologies, global presence, and strong focus on innovation in precision oncology, adaptive radiotherapy, proton therapy, and AI-enabled treatment planning. Emerging Leaders such as Sumitomo, Carl Zeiss, and Hitachi are strengthening their market presence through continuous technological advancements and specialized radiotherapy offerings. Pervasive Players, including Philips and Mevion, possess established business strategies and focused technology portfolios, particularly in imaging and proton therapy applications. Meanwhile, Participants such as MIM Software, Panacea Medical Technologies, Optivus Proton Therapy, Perspective Therapeutics, and Provision Healthcare are expanding their market presence through niche product offerings, software solutions, and specialized radiotherapy applications. Although these companies currently hold smaller market shares compared to leading players, their growing focus on innovation, strategic collaborations, and expansion into emerging application areas is expected to enhance their competitiveness in the global radiotherapy market.

radiotherapy-monitoring-devices-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2025 (Value) USD 7.58 Billion
Market Forecast in 2026 (Value) USD 7.98 Billion
Market Forecast in 2031 (Value) USD 10.68 Billion
Growth Rate CAGR of 6.0% from 2026-2031
Years Considered 2024-2031
Base Year 2025
Forecast Period 2026-2031
Units Considered Value (USD Billion)
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Segments Covered
  • By Technology:
    • LINACs
    • Particle Therapy
    • Conventional Cobalt-60 Teletherapy
  • By Offering:
    • Systems
    • Software & Services
  • By Application:
    • External Beam Radiotherapy Applications
    • Internal Beam Radiotherapy/Brachytherapy Applications
  • By Procedure:
    • External Beam Radiotherapy
    • Internal Beam Radiotherapy/Brachytherapy
  • By End User:
    • Hospitals
    • Standalone Radiotherapy Centers
Regions Covered North America, Asia Pacific, Europe, Latin America, Middle East & Africa

WHAT IS IN IT FOR YOU: RADIOTHERAPY MARKET REPORT CONTENT GUIDE

radiotherapy-monitoring-devices-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Radiotherapy System Manufacturer
  • Market sizing and growth forecast by technology (LINACs, particle therapy, conventional cobalt-60 teletherapy)
  • Procedure-wise analysis (external beam radiotherapy, internal beam radiotherapy/brachytherapy)
  • Application-wise analysis (external beam radiotherapy applications, internal beam radiotherapy/brachytherapy applications)
  • System and software & services assessment
  • End-user analysis (hospitals, independent radiotherapy centers)
  • Competitive benchmarking and regional market insights
  • Technology adoption trends and reimbursement landscape analysis
  • Identify high-growth opportunities across radiotherapy technologies and applications
  • Support product portfolio optimization and innovation strategies
  • Strengthen go-to-market and regional expansion plans
  • Assist in demand forecasting and capacity planning
  • Enhance competitive positioning and strategic decision-making
Hospitals/Independent Radiotherapy Centers
  • Technology utilization and procedure volume analysis across radiotherapy centers
  • Workflow and treatment planning assessment for external beam radiotherapy and brachytherapy
  • Evaluation of software, services, and treatment efficiency
  • Vendor comparison and equipment performance assessment
  • Cost considerations and procurement insights
  • Infrastructure and installation trend analysis
  • Improve operational efficiency and treatment workflow optimization
  • Support equipment purchasing and vendor selection decisions
  • Enhance patient treatment planning and resource allocation
  • Assist in expansion planning for radiotherapy facilities
  • Enable evidence-based investment and technology adoption decisions

RECENT DEVELOPMENTS

  • February 2025 : IBA Worldwide entered into an agreement with the Asian Institute of Gastroenterology (AIG) to provide a ProteusONE compact therapy system to support research in its oncology center.
  • January 2025 : Accuray Incorporated (US) received NMPA approval for the Radixact SynC System and the CyberKnife S7 System, which provide accurate and minimally invasive radiotherapy.
  • August 2024 : Accuray received CE Mark for the new Helical Radiation Delivery System.
  • May 2024 : Elekta launched the AI-powered adaptive CT-Linac, Evo, which is capable of delivering both offline and online adaptive radiation therapy, in addition to improving standard IGRT treatments.

 

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
 
15
2
EXECUTIVE SUMMARY
 
 
 
 
 
3
PREMIUM INSIGHTS
 
 
 
 
 
4
MARKET OVERVIEW
Explains the evolving landscape through demand-side drivers, supply-side constraints, and opportunity hotspots.
 
 
 
 
 
 
4.1
INTRODUCTION
 
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
 
4.2.4
CHALLENGES
 
 
 
 
4.3
UNMET NEEDS & WHITE SPACES
 
 
 
 
 
4.4
INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
 
5
INDUSTRY TRENDS
Maps the market evolution with focus on trend catalysts, risk factors, and growth opportunities across segments.
 
 
 
 
 
 
5.1
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
5.2
MACROECONOMIC INDICATORS
 
 
 
 
 
 
5.2.1
INTRODUCTION
 
 
 
 
 
5.2.2
HEALTHCARE EXPENDITURE & INFRASTRUCTURE OUTLOOK
 
 
 
 
 
5.2.3
TRENDS IN GLOBAL RADIOTHERAPY INDUSTRY
 
 
 
 
5.3
SUPPLY CHAIN ANALYSIS
 
 
 
 
 
 
5.4
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
5.5
ECOSYSTEM ANALYSIS
 
 
 
 
 
 
5.6
PRICING ANALYSIS
 
 
 
 
 
 
 
5.8.1
AVERAGE SELLING PRICE TREND OF RADIOTHERAPY PRODUCTS, BY KEY PLAYER, 2024–2026
 
 
 
 
 
5.8.2
AVERAGE SELLING PRICE TREND OF RADIOTHERAPY PRODUCTS, BY REGION, 2024–2026
 
 
 
 
5.7
TRADE ANALYSIS
 
 
 
 
 
 
 
5.7.1
IMPORT SCENARIO (HS CODE 300630)
 
 
 
 
 
5.7.2
EXPORT SCENARIO (HS CODE 300630)
 
 
 
 
5.8
KEY CONFERENCES & EVENTS, 2026–2027
 
 
 
 
 
5.9
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
 
 
 
 
 
5.10
INVESTMENT & FUNDING SCENARIO
 
 
 
 
 
 
5.11
CASE STUDY ANALYSIS
 
 
 
 
 
5.12
IMPACT OF 2025 US TARIFFS ON RADIOTHERAPY MARKET
 
 
 
 
 
 
 
5.12.1
INTRODUCTION
 
 
 
 
 
5.12.2
KEY TARIFF RATES
 
 
 
 
 
5.12.3
PRICE IMPACT ANALYSIS
 
 
 
 
 
5.12.4
IMPACT ON COUNTRIES/REGIONS
 
 
 
 
 
5.12.5
IMPACT ON END-USE INDUSTRIES
 
 
 
6
STRATEGIC DISRUPTIONS THROUGH TECHNOLOGY, PATENTS, AND AI ADOPTION
 
 
 
 
 
 
6.1
KEY TECHNOLOGIES
 
 
 
 
 
6.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
6.3
TECHNOLOGY/PRODUCT ROADMAP
 
 
 
 
 
6.4
PATENT ANALYSIS
 
 
 
 
 
 
6.5
FUTURE APPLICATIONS
 
 
 
 
 
6.6
IMPACT OF AI/GEN AI ON RADIOTHERAPY MARKET
 
 
 
 
 
 
 
6.6.1
TOP USE CASES & MARKET POTENTIAL
 
 
 
 
 
6.6.2
BEST PRACTICES IN RADIOTHERAPY
 
 
 
 
 
6.6.3
CASE STUDIES OF AI IMPLEMENTATION IN RADIOTHERAPY MARKET
 
 
 
 
 
6.6.4
INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS
 
 
 
 
 
6.6.5
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN RADIOTHERAPY MARKET
 
 
 
 
6.7
SUCCESS STORIES & REAL-WORLD APPLICATIONS
 
 
 
 
7
SUSTAINABILITY & REGULATORY LANDSCAPE
 
 
 
 
 
 
7.1
REGIONAL REGULATIONS & COMPLIANCE
 
 
 
 
 
 
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
7.1.2
INDUSTRY STANDARDS
 
 
 
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
 
 
 
 
 
 
8.1
DECISION-MAKING PROCESS
 
 
 
 
 
8.2
BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
 
 
 
 
 
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
 
 
 
 
 
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
 
 
 
 
9
RADIOTHERAPY MARKET, BY OFFERING ( MARKET SIZE & FORECAST TO 2031 IN VALUE, USD MILLION)
 
 
 
 
 
 
9.1
SYSTEMS
 
 
 
 
 
9.2
SOFTWARE & SERVICES ………………………………………………………………………………………
 
 
 
 
10
RADIOTHERAPY MARKET, BY TECHNOLOGY (MARKET SIZE & FORECAST TO 2031- IN VALUE, USD MILLION)
 
 
 
 
 
 
1O.1 EXTERNAL BEAM RADIOTHERAPY
 
 
 
 
 
 
 
10.1.1
LINACS
 
 
 
 
 
 
10.1.1.1
CONVENTIONAL LINACS
 
 
 
 
 
10.1.1.2
STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS
 
 
 
 
 
 
10.1.1.2.1
CYBERKNIFE
 
 
 
 
 
10.1.1.2.2
GAMMA KNIFE
 
 
 
 
 
10.1.1.2.3
TOMOTHERAPY
 
 
 
 
10.1.1.3
MRI LINACS
 
 
 
 
10.1.2
PARTICLE THERAPY
 
 
 
 
 
 
10.1.2.1
CYCLOTRONS
 
 
 
 
 
10.1.2.2
SYNCHROTRONS
 
 
 
 
 
10.1.2.3
SYNCHROCYCLOTRONS
 
 
 
 
10.1.3
CONVENTIONAL COBALT-60 TELETHERAPY
 
 
 
 
10.2
INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY
 
 
 
 
 
 
10.2.1
SEEDS
 
 
 
 
 
10.2.2
AFTERLOADERS
 
 
 
 
 
10.2.3
IORT SYSTEMS
 
 
 
 
 
10.2.4
APPLICATORS
 
 
 
11
RADIOTHERAPY MARKET, BY APPLICATION (MARKET SIZE & FORECAST TO 2031- IN VALUE, USD MILLION)
 
 
 
 
 
11
EXTERNAL BEAM RADIOTHERAPY APPLICATIONS
 
 
 
 
 
 
 
11.1.1
PROSTATE CANCER
 
 
 
 
 
11.1.2
BREAST CANCER
 
 
 
 
 
11.1.3
LUNG CANCER
 
 
 
 
 
11.1.4
HEAD & NECK CANCER
 
 
 
 
 
11.1.5
COLORECTAL CANCER
 
 
 
 
 
11.1.6
OTHER EBRT APPLICATIONS
 
 
 
 
11.2
INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS
 
 
 
 
 
 
11.2.1
PROSTATE CANCER
 
 
 
 
 
11.2.2
GYNECOLOGICAL CANCER
 
 
 
 
 
11.2.3
BREAST CANCER
 
 
 
 
 
11.2.4
CERVICAL CANCER
 
 
 
 
 
11.2.5
PENILE CANCER
 
 
 
 
 
11.2.6
OTHER IBRT APPLICATIONS
 
 
 
12
RADIOTHERAPY MARKET, BY PROCEDURE (MARKET SIZE & FORECAST TO 2031- IN VALUE, USD MILLION)
 
 
 
 
 
 
12.1
EXTERNAL BEAM RADIOTHERAPY
 
 
 
 
 
 
12.1.1
INTENSITY-MODULATED RADIOTHERAPY (IMRT)
 
 
 
 
 
12.1.2
IMAGE-GUIDED RADIOTHERAPY (IGRT)
 
 
 
 
 
12.1.3
3D CONFORMAL RADIOTHERAPY (3D-CRT)
 
 
 
 
 
12.1.4
STEREOTACTIC RADIOTHERAPY (SRT)
 
 
 
 
 
12.1.5
PARTICLE THERAPY
 
 
 
 
 
12.1.5
OTHERS
 
 
 
 
12.2
INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY
 
 
 
 
 
 
12.2.1
LDR BRACHYTHERAPY
 
 
 
 
 
12.2.2
HDR BRACHYTHERAPY
 
 
 
 
 
12.2.3
PDR BRACHYTHERAPY
 
 
 
13
RADIOTHERAPY MARKET, BY END USER (MARKET SIZE & FORECAST TO 2031- IN VALUE, USD MILLION)
 
 
 
 
 
 
13.1
HOSPITALS
 
 
 
 
 
13.2
INDEPENDENT RADIOTHERAPY CENTERS
 
 
 
 
14
RADIOTHERAPY MARKET, BY REGION (MARKET SIZE & FORECAST TO 2031- IN VALUE, USD MILLION)
 
 
 
 
 
 
14.1
INTRODUCTION
 
 
 
 
 
14.2
NORTH AMERICA
 
 
 
 
 
 
14.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
 
 
 
 
 
14.2.2
US
 
 
 
 
 
14.2.3
CANADA
 
 
 
 
14.3
EUROPE
 
 
 
 
 
 
14.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
 
 
 
 
 
14.3.2
GERMANY
 
 
 
 
 
14.3.3
UK
 
 
 
 
 
14.3.4
FRANCE
 
 
 
 
 
14.3.5
ITALY
 
 
 
 
 
14.3.6
SPAIN
 
 
 
 
 
14.3.7
REST OF EUROPE (ROE)
 
 
 
 
14.4
ASIA PACIFIC
 
 
 
 
 
 
14.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
 
 
 
 
 
14.4.2
CHINA
 
 
 
 
 
14.4.3
JAPAN
 
 
 
 
 
14.4.4
INDIA
 
 
 
 
 
14.4.5
SOUTH KOREA
 
 
 
 
 
14.4.6
AUSTRALIA
 
 
 
 
 
14.4.7
REST OF ASIA PACIFIC (ROAPAC)
 
 
 
 
14.5
LATIN AMERICA
 
 
 
 
 
 
14.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
 
 
 
 
 
14.5.2
BRAZIL
 
 
 
 
 
14.5.3
MEXICO
 
 
 
 
 
14.5.4
REST OF LATIN AMERICA (ROLA)
 
 
 
 
14.6
MIDDLE EAST & AFRICA
 
 
 
 
 
 
14.6.1
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
 
 
 
 
 
14.6.2
GCC COUNTRIES
 
 
 
 
 
14.6.3
REST OF MIDDLE EAST & AFRICA (ROMEA)
 
 
 
15
COMPETITIVE LANDSCAPE
 
 
 
 
 
 
15.1
OVERVIEW
 
 
 
 
 
15.2
KEY PLAYER STRATEGIES/RIGHT TO WIN (2023–2026)
 
 
 
 
 
15.3
REVENUE ANALYSIS (2023–2025)
 
 
 
 
 
 
15.4
MARKET SHARE ANALYSIS (2025)
 
 
 
 
 
 
15.5
COMPANY EVALUATION MATRIX: KEY PLAYERS,
 
 
 
 
 
 
 
15.5.1
STARS
 
 
 
 
 
15.5.2
EMERGING LEADERS
 
 
 
 
 
15.5.3
PERVASIVE PLAYERS
 
 
 
 
 
15.5.4
PARTICIPANTS
 
 
 
 
 
15.5.5
COMPANY FOOTPRINT: KEY PLAYERS,
 
 
 
 
 
 
15.5.5.1
COMPANY FOOTPRINT
 
 
 
 
 
15.5.5.2
REGION FOOTPRINT
 
 
 
 
 
15.5.5.3
PRODUCT TYPE FOOTPRINT
 
 
 
 
 
15.5.5.4
TECHNOLOGY FOOTPRINT
 
 
 
 
 
15.5.5.5
APPLICATIONFOOTPRINT
 
 
 
 
 
15.5.5.6
END-USER FOOTPRINT
 
 
 
15.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES,
 
 
 
 
 
 
 
15.6.1
PROGRESSIVE COMPANIES
 
 
 
 
 
15.6.2
RESPONSIVE COMPANIES
 
 
 
 
 
15.6.3
DYNAMIC COMPANIES
 
 
 
 
 
15.6.4
STARTING BLOCKS
 
 
 
 
 
15.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SME,
 
 
 
 
 
 
15.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
 
15.6.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
 
15.7
COMPETITIVE SCENARIO)
 
 
 
 
 
 
15.7.1
PRODUCT LAUNCHES & APPROVALS
 
 
 
 
 
15.7.2
DEALS
 
 
 
 
 
15.7.3
OTHER DEVELOPMENTS
 
 
 
 
15.8
BRAND/PRODUCT COMPARISON
 
 
 
 
 
 
15.9
COMPANY VALUATION & FINANCIAL METRICS
 
 
 
 
16
COMPANY PROFILES
 
 
 
 
 
 
16.1
KEY PLAYERS
 
 
 
 
 
 
16.1.1
SIEMENS HEALTHINEERS GMBH
 
 
 
 
 
16.1.2
ELEKTA
 
 
 
 
 
16.1.3
ACCURAY INCORPORATED
 
 
 
 
 
16.1.4
IBA WORLDWIDE (ION BEAM APPLICATIONS SA)
 
 
 
 
 
16.1.5
VIEWRAY TECHNOLOGIES, INC.
 
 
 
 
 
16.1.6
HITACHI LTD.
 
 
 
 
 
16.1.7
SUMITOMO HEAVY INDUSTRIES LTD.
 
 
 
 
 
16.1.8
CARL ZEISS MEDITEC AG
 
 
 
 
 
16.1.9
MIM SOFTWARE INC.
 
 
 
 
 
16.1.10
PANACEA MEDICAL TECHNOLOGIES PVT. LTD.
 
 
 
 
 
16.1.11
PROVISION HEALTHCARE
 
 
 
 
 
16.1.12
MEVION MEDICAL SYSTEMS
 
 
 
 
 
16.1.12
OPTIVUS PROTON THERAPY, INC.
 
 
 
 
 
16.1.14
PHILIPS HEALTHCARE
 
 
 
 
16.2
OTHER COMPANIES
 
 
 
 
 
 
16.2.1
INTRAOP MEDICAL
 
 
 
 
 
16.2.2
BEBIG MEDICAL
 
 
 
 
 
16.2.3
P-CURE
 
 
 
 
 
16.2.4
RAYSEARCH LABORATORIES
 
 
 
 
 
16.2.5
THERAGENICS
 
 
 
 
 
16.2.6
PROTOM INTERNATIONAL
 
 
 
 
 
16.2.7
DOSISOFT SA.
 
 
 
 
 
16.2.8
ISOAID
 
 
 
 
 
16.2.9
MAGNETTX ONCOLOGY SOLUTIONS LTD.
 
 
 
 
 
16.2.10
PERSPECTIVE THERAPEUTICS, INC.
 
 
 
 
 
16.2.11
BRAINLAB AG
 
 
 
 
 
16.2.12
SHINVA MEDICAL INSTRUMENT CO., LTD.
 
 
 
17
RESEARCH METHODOLOGY
 
 
 
 
 
 
17.1
RESEARCH DATA SOURCES
 
 
 
 
 
 
17.1.1
SECONDARY RESEARCH
 
 
 
 
 
17.1.2
PRIMARY RESEARCH
 
 
 
 
17.2
MARKET SIZE ESTIMATION
 
 
 
 
 
17.3
MARKET FORECASTING APPROACH
 
 
 
 
 
17.4
MARKET BREAKDOWN & DATA TRIANGULATION
 
 
 
 
 
17.5
RESEARCH ASSUMPTIONS
 
 
 
 
 
17.6
RESEARCH LIMITATIONS
 
 
 
 
 
 
17.6.1
SCOPE-RELATED LIMITATIONS
 
 
 
 
 
17.6.2
METHODOLOGY-RELATED LIMITATIONS
 
 
 
 
17.7
RISK ASSESSMENT
 
 
 
 
18
APPENDIX
 
 
 
 
 
 
18.1
DISCUSSION GUIDE
 
 
 
 
 
18.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
 
18.3
CUSTOMIZATION OPTIONS
 
 
 
 
 
18.4
RELATED REPORTS
 
 
 
 
 
18.5
AUTHOR DETAILS
 
 
 
 

Methodology

This study involved the extensive use of both primary and secondary sources. Exhaustive secondary research was done to collect information on the radiotherapy industry. The next step was to validate these findings, assumptions, and sizing estimates with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market sizes of the radiotherapy market's segments and subsegments. The research process involved examining various factors affecting the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and key players' strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, Companies House documents, investor presentations, and SEC filings. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the radiotherapy market. It was also used to obtain important information about key players, market classification & segmentation according to industry trends, down to the bottom-most level, and key developments from market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

The market for companies offering radiotherapy products is derived from secondary data available through paid and unpaid sources, by analyzing the product portfolios of the major companies in the ecosystem and rating them by performance and quality. Various sources were consulted during the secondary research process to identify and collect information for this study. Secondary research was used to obtain critical information on the industry's value chain, the total pool of key players, market classification, and segmentation from market- and technology-oriented perspectives.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the radiotherapy market. The primary sources from the demand side include OEMs, private and contract testing organizations, and service providers, among others. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

After the complete market engineering (calculations for market statistics, market breakdown, market estimation, market forecasting and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at fill primary research was also conducted to identify the segmentation types industry trends competitive landscape of radiotherapy offered by various market players and key market dynamics such as drivers, restraints, opportunities, challenges, industry trends and key players strategies.

In the complete market engineering process, the top-down and bottom-up approaches were extensively used, along with several data regulation methods, to perform market estimation and forecasting across the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analyses were conducted across the entire market engineering process to identify key insights throughout the report.

A breakdown of the primary respondents is provided below:

Radiotherapy Market
 Size, and Share

Note 1: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note 2: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 2 billion, Tier 2 = USD 50 million to USD 2 billion, and Tier 3 = <USD 50 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the radiotherapy market. These methods were also used extensively to estimate the size of various market segments.

To determine the size of the global radiotherapy market, revenue share analysis was employed with the leading players. In this case, key market players have been identified, and their radiotherapy product business revenues have been determined using insights gathered during the primary and secondary research phases. Secondary research included the study of top market players' annual and financial reports. On the other hand, primary research included in-depth interviews with key opinion leaders, particularly chief executive officers, directors, and key marketing executives.

Radiotherapy Market : Top-Down and Bottom-Up Approach

Radiotherapy Market Top Down and Bottom Up Approach

Data Triangulation

After arriving at the overall market size through the market size estimation process described above, the global radiotherapy market was segmented. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the radiotherapy market was validated using both top-down and bottom-up approaches.

Market Definition

The radiotherapy market includes a range of products, solutions, technologies, and services that utilize high-energy radiation for therapeutic purposes. This encompasses various types of radiation, such as X-ray, gamma, electron, and particle radiation. The technologies segment of radiotherapy features systems designed to treat diseases, primarily cancer. This includes external beam radiotherapy methods like LINAC, MRI-LINAC, and cobalt-60 teletherapy. Additionally, internal radiotherapy solutions, commonly known as brachytherapy, are also part of this market segment. Other components of the radiotherapy market include software for imaging and treatment planning. Furthermore, the market provides maintenance and training services related to radiotherapy technologies.

Key Stakeholders

  • Radiotherapy product manufacturing companies
  • Distributors, suppliers, and commercial service providers
  • Healthcare service providers
  • Clinical research organizations (CROs)
  • Radiotherapy service providers
  • Radiotherapy product distributors
  • Medical research laboratories
  • Cancer care centers
  • Cancer research organizations
  • Academic medical centers and universities
  • Market research and consulting firms

Report Objectives

  • To define, describe, and forecast the radiotherapy market based on offering, technology, application, procedure, end user, and region
  • To provide detailed information regarding the major factors influencing the growth potential of the global radiotherapy market (drivers, restraints, opportunities, challenges, and trends)
  • To analyze the micromarkets for individual growth trends, prospects, and contributions to the global radiotherapy market
  • To analyze key growth opportunities in the global radiotherapy market for key stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of market segments and/or subsegments with respect to five major regions: North America (the US and Canada), Europe (Germany, the UK, France, Italy, Spain, and the Rest of Europe), Asia Pacific (Japan, China, India, Australia, South Korea, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), and the Middle East & Africa (GCC Countries and the Rest of Middle East & Arica)
  • To profile the key players in the global radiotherapy market and comprehensively analyze their market shares and core competencies
  • To track and analyze the competitive developments undertaken in the global radiotherapy market, such as agreements, expansions, and product launches

Available customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present global radiotherapy market report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top 16 companies

Company Information

  • Detailed analysis and profiling of additional market players (up to 15)

Geographic Analysis

  • Further breakdown of the Rest of Europe radiotherapy market into Russia, Belgium, the Netherlands, Switzerland, Austria, Finland, Sweden, Poland, and Portugal, among others
  • Further breakdown of the Rest of Asia Pacific radiotherapy market into Singapore, Taiwan, New Zealand, the Philippines, Malaysia, and other APAC countries
  • Further breakdown of the Rest of Latin America radiotherapy market into Argentina, Chile, Peru, and Colombia, among others

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Radiotherapy Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

TESTIMONIALS

Growth opportunities and latent adjacency in Radiotherapy Market

DMCA.com Protection Status